glp 1 anaesthesia A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia | Journal of Anesthesia, Analgesia and Critical Care Glucagon-Like Peptide-1 Agonists and General
Description
While its effective for headaches, muscle aches, and fever, its not without risks when combined with other substances
But theres a tradeoff
The evidence base in support of the use of medicines based on glucagon-like peptide 1 beyond glucose control and weight loss was substantially bolstered in 2024, as clinical trial data report benefits of these medicines in people with a range of disorders.
The degradation product GLP-1(936) shared this capacity
Childhood obesity rates have skyrocketed over 300% since the 1970s, now affecting 21% of children
